Drugs / Travaprost
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03292796 | Dec 2016 → Oct 2019 | open-angle glaucoma | Julie Dawson | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00799682 Comparator | Oct 2008 → Jan 2011 | dry eye syndrome | Ophthalmic Consultants of Long Island | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Travaprost | “Topical Prostaglandin, Travaprost Ophthalmic Solution” NCT00799682 ↗1“Latanoprost Travaprost Bimatoprost Tafluprost” NCT03292796 ↗ |
| Route | Topical | “Topical Prostaglandin, Travaprost Ophthalmic Solution” NCT00799682 ↗ |